Lixte Biotechnology Inc. (LIXT)
NASDAQ: LIXT
· Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT
Lixte Biotechnology Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.79 | -1.05 | -1.85 | -1.07 | -1.33 | -2.07 | -1.28 | -1.25 | -1.47 | -2.52 | -1.31 | -1.58 | -1.94 | -2.55 | -2.01 | -5.76 | -5.96 | -6.08 |
PEG Ratio | n/a | -0.14 | 0.05 | 0.48 | -0.29 | 0.32 | 0.21 | 0.02 | -0.07 | 0.15 | -0.13 | 0.25 | 0.09 | 0.13 | -0.03 | 0.20 | 1.01 | -0.08 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.78 | 2.58 | 5.52 | 3.08 | 2.39 | 2.57 | 1.32 | 1.03 | 3.64 | 3.39 | 1.64 | 1.45 | 1.60 | 4.87 | 3.41 | 4.70 | 6.01 | 5.49 |
P/FCF Ratio | -5.05 | -5.26 | -7.63 | -4.39 | -6.56 | -10.17 | -5.86 | -5.38 | -8.33 | -10.87 | -7.03 | -7.94 | -10.04 | -16.33 | -14.26 | -30.78 | -39.64 | -40.9 |
P/OCF Ratio | -5.05 | -5.26 | -7.63 | -4.39 | -6.56 | -10.17 | -5.86 | -5.38 | -8.33 | -10.87 | -7.03 | -7.94 | -10.04 | -16.33 | -14.26 | -30.78 | -39.64 | -40.9 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 1.84 | 4.26 | 3.60 | 5.13 | 6.33 | 7.59 | 13.73 | 16.79 | 7.69 | 17.32 | 14.08 | 16.70 | 15.10 | 6.37 | 16.81 | 24.38 | 19.25 | 32.55 |
Current Ratio | 1.84 | 4.26 | 3.60 | 5.13 | 6.33 | 7.59 | 13.73 | 16.79 | 7.69 | 17.32 | 14.08 | 16.70 | 15.10 | 6.37 | 16.81 | 24.38 | 19.25 | 32.55 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 428.07 | -225.5 | -138.31 | -937.33 | -242.9 | -134.57 | -101.12 | -3.67K | -857.29 | -354.87 | -449.24 | -697.74 | -2.47K | -663.33 | -453.01 | n/a | -2.05K | -817.54 |
Return on Equity | -1.19 | -0.61 | -0.75 | -0.72 | -0.45 | -0.31 | -0.26 | -0.21 | -0.62 | -0.34 | -0.31 | -0.23 | -0.21 | -0.48 | -0.42 | -0.2 | -0.25 | -0.23 |
Return on Assets | -0.65 | -0.47 | -0.54 | -0.58 | -0.38 | -0.27 | -0.24 | -0.19 | -0.54 | -0.32 | -0.29 | -0.22 | -0.19 | -0.4 | -0.4 | -0.2 | -0.24 | -0.22 |
Return on Invested Capital | -1.19 | -0.61 | -0.74 | -0.72 | -0.45 | -0.31 | -0.25 | -0.2 | -0.6 | -0.33 | -0.31 | -0.23 | -0.2 | -0.48 | -0.41 | -0.2 | -0.24 | -0.23 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |